Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juergen R Schaefer

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 2005
Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosisKatsunori Ikewaki, Juergen R Schaefer, Michael E Frischmann, et al.
The European Journal of General Practice|November 4, 2009
Chest pain in primary care: epidemiology and pre-work-up probabilitiesStefan Bösner, Annette Becker, Jörg Haasenritter, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 7, 2010
Ruling out coronary artery disease in primary care: development and validation of a simple prediction ruleStefan Bösner, Jörg Haasenritter, Annette Becker, et al.
Pediatric Nephrology (Berlin, Germany)|March 5, 2018
Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensityGünter Klaus, Christina Taylan, Rainer Büscher, et al.
Clinical Therapeutics|May 4, 2010
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trialRoeland Huijgen, Evertine J Abbink, Eric Bruckert, et al.
The American Journal of Cardiology|September 18, 2020
Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein ApheresisChristina Taylan, Joenna Driemeyer, Claus P Schmitt, et al.
Studies in Health Technology and Informatics|June 25, 2020
The Status Quo of Rare Diseases Centres for the Development of a Clinical Decision Support System - A Cross-Sectional StudyJannik Schaaf, Martin Sedlmayr, Hans-Ulrich Prokosch, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 2005
Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosisKatsunori Ikewaki, Juergen R Schaefer, Michael E Frischmann, et al.
The European Journal of General Practice|November 4, 2009
Chest pain in primary care: epidemiology and pre-work-up probabilitiesStefan Bösner, Annette Becker, Jörg Haasenritter, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 7, 2010
Ruling out coronary artery disease in primary care: development and validation of a simple prediction ruleStefan Bösner, Jörg Haasenritter, Annette Becker, et al.
Pediatric Nephrology (Berlin, Germany)|March 5, 2018
Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensityGünter Klaus, Christina Taylan, Rainer Büscher, et al.
Clinical Therapeutics|May 4, 2010
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trialRoeland Huijgen, Evertine J Abbink, Eric Bruckert, et al.
The American Journal of Cardiology|September 18, 2020
Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein ApheresisChristina Taylan, Joenna Driemeyer, Claus P Schmitt, et al.
Studies in Health Technology and Informatics|June 25, 2020
The Status Quo of Rare Diseases Centres for the Development of a Clinical Decision Support System - A Cross-Sectional StudyJannik Schaaf, Martin Sedlmayr, Hans-Ulrich Prokosch, et al.
Pageof 4